46 related articles for article (PubMed ID: 38460931)
1. A nanomedicine composed of polymer-ss-DOX and polymer-Ce6 prodrugs with monoclonal antibody targeting effect for anti-tumor chemo-photodynamic synergetic therapy.
Yu L; Zhang M; He J; Sun X; Ni P
Acta Biomater; 2024 Apr; 179():272-283. PubMed ID: 38460931
[TBL] [Abstract][Full Text] [Related]
2. Targeted Chemo-Photodynamic Combination Platform Based on the DOX Prodrug Nanoparticles for Enhanced Cancer Therapy.
Zhang Y; Huang F; Ren C; Yang L; Liu J; Cheng Z; Chu L; Liu J
ACS Appl Mater Interfaces; 2017 Apr; 9(15):13016-13028. PubMed ID: 28378992
[TBL] [Abstract][Full Text] [Related]
3. Near-Infrared Light Triggered ROS-activated Theranostic Platform based on Ce6-CPT-UCNPs for Simultaneous Fluorescence Imaging and Chemo-Photodynamic Combined Therapy.
Yue C; Zhang C; Alfranca G; Yang Y; Jiang X; Yang Y; Pan F; de la Fuente JM; Cui D
Theranostics; 2016; 6(4):456-69. PubMed ID: 26941840
[TBL] [Abstract][Full Text] [Related]
4. Programmable co-delivery of the immune checkpoint inhibitor NLG919 and chemotherapeutic doxorubicin via a redox-responsive immunostimulatory polymeric prodrug carrier.
Sun JJ; Chen YC; Huang YX; Zhao WC; Liu YH; Venkataramanan R; Lu BF; Li S
Acta Pharmacol Sin; 2017 Jun; 38(6):823-834. PubMed ID: 28504251
[TBL] [Abstract][Full Text] [Related]
5. Oxygen Self-Supplied Perfluorocarbon-Modified Micelles for Enhanced Cancer Photodynamic Therapy and Ferroptosis.
Ren H; Hao M; Liu G; Li J; Jiang Z; Meng W; Zhang Y
ACS Appl Bio Mater; 2024 May; 7(5):3306-3315. PubMed ID: 38634490
[TBL] [Abstract][Full Text] [Related]
6. Doxorubicin delivered by a redox-responsive dasatinib-containing polymeric prodrug carrier for combination therapy.
Sun J; Liu Y; Chen Y; Zhao W; Zhai Q; Rathod S; Huang Y; Tang S; Kwon YT; Fernandez C; Venkataramanan R; Li S
J Control Release; 2017 Jul; 258():43-55. PubMed ID: 28501705
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic effect of vascular-targeted polyphenol nanoparticles on Endothelial cells.
Yang L; Liu D; Liu L; Jiang X
Photodiagnosis Photodyn Ther; 2024 Jun; 47():104096. PubMed ID: 38643893
[TBL] [Abstract][Full Text] [Related]
8. Tumor-targeted and stimulus-responsive polymeric prodrug nanoparticles to enhance the anticancer therapeutic efficacy of doxorubicin.
Kim N; Kwon S; Kwon G; Song N; Jo H; Kim C; Park S; Lee D
J Control Release; 2024 May; 369():351-362. PubMed ID: 38552963
[TBL] [Abstract][Full Text] [Related]
9. Reduction-responsive PEtOz-SS-PCL micelle with tailored size to overcome blood-brain barrier and enhance doxorubicin antiglioma effect.
Li Y; Baiyang L; Leran B; Zhen W; Yandong X; Baixiang D; Dandan Z; Yufu Z; Jun L; Rutong Y; Hongmei L
Drug Deliv; 2017 Nov; 24(1):1782-1790. PubMed ID: 29172749
[TBL] [Abstract][Full Text] [Related]
10. Spatiotemporally-controlled hydrophobic drug delivery via photosensitizer-driven assembly-disassembly for enhanced triple-negative breast cancer treatment.
Kong F; He P; Jiang J; Zhu W; Lei Q
J Control Release; 2024 May; 369():53-62. PubMed ID: 38513728
[TBL] [Abstract][Full Text] [Related]
11. Chitosan oligosaccharide-functionalized nano-prodrug for cascade chemotherapy through oxidative stress amplification.
Cui L; Xu Q; Lou W; Wang Y; Xi X; Chen Y; Sun M; Wang Z; Zhang P; Yang S; Zhang L; Qu L
Int J Biol Macromol; 2024 May; 268(Pt 2):131641. PubMed ID: 38641277
[TBL] [Abstract][Full Text] [Related]
12. Porphyrin-based covalent organic frameworks as doxorubicin delivery system for chemo-photodynamic synergistic therapy of tumors.
Chen P; Li Y; Dai Y; Wang Z; Zhou Y; Wang Y; Li G
Photodiagnosis Photodyn Ther; 2024 Apr; 46():104063. PubMed ID: 38527660
[TBL] [Abstract][Full Text] [Related]
13. Supramolecular Nanoparticles of Histone and Hyaluronic Acid for Co-Delivery of siRNA and Photosensitizer In Vitro.
Hu M; Bao J; Zhang Y; Wang L; Zhang Y; Zhang J; Tang J; Zou Q
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791462
[TBL] [Abstract][Full Text] [Related]
14. Chimeric Peptide-Engineered Self-Delivery Nanomedicine for Photodynamic-Triggered Breast Cancer Immunotherapy by Macrophage Polarization.
Liu YB; Chen XY; Yu BX; Cen Y; Huang CY; Yan MY; Liu QQ; Zhang W; Li SY; Tang YZ
Small; 2024 May; 20(22):e2309994. PubMed ID: 38095445
[TBL] [Abstract][Full Text] [Related]
15. Dual approach: micellar delivery of chlorambucil prodrug with concurrent glutathione depletion and GST inhibition for enhanced anticancer activity.
Wu S; Liao K; Chen J; Li F
Nanotechnology; 2024 Jun; 35(34):. PubMed ID: 38788695
[TBL] [Abstract][Full Text] [Related]
16. Polyprodrug nanomedicine for chemiexcitation-triggered self-augmented cancer chemotherapy and gas therapy.
Wang Q; Zhang C; Zhao Y; Jin Y; Zhou S; Qin J; Zhang W; Hu Y; Chen X; Yang K
Biomaterials; 2024 Sep; 309():122606. PubMed ID: 38776593
[TBL] [Abstract][Full Text] [Related]
17. Glutathione-degradable drug-loaded nanogel effectively and securely suppresses hepatoma in mouse model.
Liu X; Wang J; Xu W; Ding J; Shi B; Huang K; Zhuang X; Chen X
Int J Nanomedicine; 2015; 10():6587-602. PubMed ID: 26543363
[TBL] [Abstract][Full Text] [Related]
18. Chlorin e6-Conjugated Mesoporous Titania Nanorods as Potential Nanoplatform for Photo-Chemotherapy.
Vélez-Peña E; Jiménez VA; Manzo-Merino J; Alderete JB; Campos CH
Nanomaterials (Basel); 2024 May; 14(11):. PubMed ID: 38869558
[TBL] [Abstract][Full Text] [Related]
19. Tumor-penetrating iRGD facilitates penetration of poly(floxuridine-ketal)-based nanomedicine for enhanced pancreatic cancer therapy.
Li X; Zhong H; Zheng S; Mu J; Yu N; Guo S
J Control Release; 2024 May; 369():444-457. PubMed ID: 38575076
[TBL] [Abstract][Full Text] [Related]
20. NK-92 cells labeled with Fe
Lian J; Li M; Duan M; Sun Y; Wang Z; Guo X; Li J; Gao G; Li K
J Nanobiotechnology; 2024 Jun; 22(1):313. PubMed ID: 38840120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
